Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.

Earlier Intervention for Mitral Valve Disease May Lead to Improved Outcomes
News | Heart Valve Technology | July 26, 2018
July 26, 2018 — The number of patients undergoing mitral valve operations are at an all-time high, and new research...
Abbott Recalls the HeartMate 3 Left Ventricular Assist System, LVAD
News | Ventricular Assist Devices (VAD) | May 23, 2018
May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a...
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

 

Feature | Antiplatelet and Anticoagulation Therapies | May 07, 2018
May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
April 30, 2018 – Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was...
LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China
News | Heart Valve Technology | March 30, 2018
March 30, 2018 — LivaNova PLC announced the first patient enrollment in the Perceval Valve Clinical study for Chinese...
Contrast-Free Cardiac MRI May Better Assess Need for Mitral Valve Surgery
News | Magnetic Resonance Imaging (MRI) | February 27, 2018
February 27, 2018 – A new study published in the Journal of the American College of Cardiology confirms non-invasive...
AtriCure Launches AtriClip FLEX•V Device in the United States
Technology | Left Atrial Appendage (LAA) Occluders | February 22, 2018
February 22, 2018 — AtriCure Inc. announced that it has launched the AtriClip FLEX•V Left Atrial Appendage (LAA)...
Technavio Market Study Shows Donor Shortage and Improved Survival Rate
News | Hemodynamic Support Devices | January 25, 2018
January 25, 2018 – According to the latest market study released by Technavio, the global circulatory support devices...
Secant Introduces First Synthetic Regenerative Cardiovascular Graft for CABG
News | Stem Cell Therapies | January 17, 2018
January 17, 2018 — Secant Group, in partnership with its sister company SanaVita Medical, announced new technology to...
CMS Announces Final Changes, Cancellations of Mandatory Bundled Payment Models
News | Cardiovascular Business | December 21, 2017
December 21, 2017 — The Centers for Medicare & Medicaid Services (CMS) last week finalized the cancellation of the...
CorInnova Awarded 2017 InnoSTARS Prize for EpicHeart Soft Robotic Heart Assist Device
News | Artificial Heart | December 11, 2017
December 11, 2017 — CorInnova Inc. recently announced it was awarded second prize in the “2017 InnoSTARS” life science...
Studies find 15 percent of all heart attack and stroke patients and 9 percent of CABG patients were uninsured before passage of the Affordable Care Act. AHA 2017, #aha2017
News | November 25, 2017
November 25, 2017 — The majority of patients without health insurance who were hospitalized for heart attack, stroke or...
Surgery Could Reduce Frailty in Adults With Heart Failure
News | Heart Failure | November 17, 2017
November 17, 2017 — Common practice, and recently published research, shows that the risk of complications with surgery...
German Hospital Plans Life-Saving Vascular Surgeries With 3-D Printing

Transparent Stratasys 3-D-printed model of a patient-specific aortic arch, used by the University Hospital Mainz to practice complex endovascular surgeries. Photo courtesy of Business Wire.

News | Medical 3-D Printing | November 16, 2017
November 16, 2017 — Stratasys Ltd. announced that surgeons at the University of Mainz Cardiothoracic and Vascular...
HREVS study principal investigator Vladimir Ganyukov, M.D., Ph.D., head of interventional cardiology, State Scientific Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia, at TCT 2017.

Study principal investigator Vladimir Ganyukov, M.D., Ph.D., head of interventional cardiology, State Scientific Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia, explaining the HREVS trial results at TCT 2017.

News | November 06, 2017 | Dave Fornell
November 6, 2017 — In the Hybrid REvascularization Versus Standards (HREVS) study that evaluated three different...